Kala Pharmaceuticals Inc

$2.05 0.00% ($0.00)

Get ready to invest

About Kala Pharmaceuticals Inc

Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles, or MPP, technology. The Company’s initial focus is on the treatment of eye diseases. The Company’s product candidate includes KPI-121 1%, KPI-121 0.25% and MPP rTKI Program. The Company has completed two Phase III clinical trials for KPI-121 1% . The KPI-121 0.25% is the Company’s product candidate for temporary relief of signs and symptoms of dry eye disease. KPI-121 1% is the twice-a-day product candidate for treatment of post-operative inflammation and pain following ocular surgery. MPP rTKI Program is therapies for retinal diseases that should be injected directly into the patient's eye, often at monthly intervals.

Popular Stocks	Price	Change
Snap SNAP	$55.14 8.44%	8.44%
Intel INTC	$49.46 0.7%	0.7%
Itau ITUB	$4.13 0.24%	0.24%
Petrobras PBR	$9.95 1.64%	1.64%
Banco Bradesco Pref Shares BBD	$3.6 1.64%	1.64%
Ford F	$16.28 0.31%	0.31%
Cleveland-Cliffs CLF	$23.85 7.19%	7.19%
Apple AAPL	$148.69 0.52%	0.52%
Ambev ABEV	$2.62 1.95%	1.95%